Satellos Bioscience Inc. Increase Decrease In Cash And Cash Equivalents
Satellos Bioscience Inc. (MSLE) reported Increase Decrease In Cash And Cash Equivalents of -$30.27 million for the 12-month period ending 2025-12-31, per its 40-F filed 2026-03-27.
Financial Statements › Notes
ifrs-full:IncreaseDecreaseInCashAndCashEquivalents · last filed 2026-03-27
| Period end | Increase Decrease In Cash And Cash Equivalents 12 month |
|---|---|
| 2025-12-31 | -$30.27M 40-F · filed 2026-03-27 |
| 2024-12-31 | $23.39M 40-F · filed 2026-03-27 |